Adenovirus Early Region 1A protein (E1A) (E1A)

Adenovirus Early Region 1A (E1A) protein is a multifunctional viral oncoprotein that serves as the primary regulator of the adenovirus life cycle and a potent modulator of host cell physiology. It lacks intrinsic DNA-binding activity and instead functions as a molecular hub that physically interacts with and hijacks key components of the host transcriptional machinery, most notably the Retinoblastoma (Rb) family of proteins and the p300/CBP histone acetyltransferases (UniProt P03255; Pelka et al., 2008). By sequestering Rb, E1A disrupts the Rb-E2F complex, thereby releasing E2F transcription factors to drive the host cell into the S-phase, which is essential for viral DNA replication (Gallimore & Turnell, 2001). Additionally, E1A recruits p300/CBP to viral and cellular promoters, leading to large-scale changes in histone acetylation and chromatin structure that favor viral gene expression and suppress host antiviral defenses (Berk, 2005). In therapeutic contexts, E1A is a central component in the development of oncolytic adenoviruses, such as Onyx-015 or DNX-2401, which are engineered with E1A deletions or modifications to ensure they selectively replicate in cancer cells with defective cell cycle checkpoints (NIH/NCI; Lang et al., 2018). While E1A is a powerful tool for cancer therapy, its ability to globally reprogram host transcription presents challenges regarding systemic toxicity and the induction of potent immune responses against the viral vector.

Other names

AdE1AEarly region 1A proteinE1A oncoproteinAdenovirus E1AE1A 12SE1A 13S

E1A hijacks host transcriptional machinery by binding to the Retinoblastoma (Rb) protein to release E2F transcription factors and recruiting p300/CBP to modify chromatin, thereby inducing S-phase and viral gene expression.